WHO ICTRP trial
PHASE 2 CLINICAL STUDY OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN SUBJECTS WITH…
EUCTR2016-000742-61-IT · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2016-000742-61-IT |
|---|---|
| Public title | PHASE 2 CLINICAL STUDY OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN SUBJECTS WITH UNRESECTABLE OR METASTATIC MELANOMA. (NIVOLUMAB-IPILIMUMAB AT 1MG/KG – NIVOIPI01) |
| Scientific title | CLINICAL STUDY OF NIVOLUMAB COMBINED WITH IPILIMUMAB IN SUBJECTS WITH UNRESECTABLE OR METASTATIC MELANOMA. (NIVOLUMABIPILIMUMAB AT 1MG/KG – NIVOIPI01) - NA |
| Primary sponsor | AZIENDA OSPEDALIERO-UNIVERSITARIA PISANA |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Italy |
| Conditions | Adult unresectable metastatic melanoma patients either non pretreated or pretreated with B-Raf inhibitors or their combination with MEK inhibitors MedDRA version: 20.0 Level: LLT Classification code 10027481 Term: Metastatic melanoma System… |
| Interventions | Trade Name: YERVOY - 5 MG/ML - CONCENTRATO PER SOLUZIONE PER INFUSIONE - USO ENDOVENOSO - FLACONCINO (VETRO) - 40 ML 1 FLACONCINO Product Name: IPILIMUMAB Product Code: NA Pharmaceutical Form: Concentrate for solution for infusion INN or… |
| Registration date | Jan 30, 2018 |
| Target size | 60 |
| Secondary IDs | nivoipi01 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: